2013 annual financial data
Atossa Therapeutics 2013 Operating margin
Direct answer
Operating margin was -1,704.93%.
Operating income was -10,784,643 USD and net income was -10,784,708 USD.
Operating cash flow was -8,830,044 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 632,558 USD
- Operating income
- -10,784,643 USD
- Net income
- -10,784,708 USD
- Operating cash flow
- -8,830,044 USD